Hypoxia in head and neck cancer: Studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins

被引：26
作者：
Rischin, Danny
Fisher, Richard
Peters, Lester
Corry, June
Hicks, Rodney
机构：
[1] Peter MacCallum Canc Ctr, Div Haematol & Med Oncol, Melbourne, Vic 8006, Australia
[2] Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Ctr Mol Imaging, Melbourne, Vic, Australia
[5] Univ Melbourne, Melbourne, Vic, Australia
[6] Trans Tasman Radiat Oncol Grp, Newcastle, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2007.05.043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S61 / S63
页数：3
相关论文
共 7 条
[1]   SR-4233 (TIRAPAZAMINE) - A NEW ANTICANCER DRUG EXPLOITING HYPOXIA IN SOLID TUMORS [J].
BROWN, JM .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1163-1170
[2]   EVALUATION OF OXYGENATION STATUS DURING FRACTIONATED RADIOTHERAPY IN HUMAN NONSMALL CELL LUNG CANCERS USING [F-18] FLUOROMISONIDAZOLE POSITRON EMISSION TOMOGRAPHY [J].
KOH, WJ ;
BERGMAN, KS ;
RASEY, JS ;
PETERSON, LM ;
EVANS, ML ;
GRAHAM, MM ;
GRIERSON, JR ;
LINDSLEY, KL ;
LEWELLEN, TK ;
KROHN, KA ;
GRIFFIN, TW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (02) :391-398
[3]   Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: A phase II study [J].
Lee, DJ ;
Trotti, A ;
Spencer, S ;
Rostock, R ;
Fisher, C ;
von Roemeling, R ;
Harvey, E ;
Groves, EG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :811-815
[4]   Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study [J].
Nordsmark, M ;
Bentzen, SM ;
Rudat, V ;
Brizel, D ;
Lartigau, E ;
Stadler, P ;
Becker, A ;
Adam, M ;
Molls, M ;
Dunst, J ;
Terriis, DJ ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 77 (01) :18-24
[5]   Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02 [J].
Rischin, D ;
Hicks, RJ ;
Fisher, R ;
Binns, D ;
Corry, J ;
Porceddu, S ;
Peters, LJ .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2098-2104
[6]   Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer [J].
Rischin, D ;
Peters, L ;
Hicks, R ;
Hughes, P ;
Fisher, R ;
Hart, R ;
Sexton, M ;
D'Costa, I ;
von Roemeling, R .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :535-542
[7]   Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02) [J].
Rischin, D ;
Peters, L ;
Fisher, R ;
Macann, A ;
Denham, J ;
Poulsen, M ;
Jackson, M ;
Kenny, L ;
Penniment, M ;
Corry, J ;
Lamb, D ;
McClure, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :79-87
1